Cargando…
Evaluation of SARS-CoV-2 infection risks after primary vaccination with BNT162b2, BBIBP-CorV, or ChAdOx1-nCOV-19 and after homologous and heterologous booster vaccinations with these vaccines and evaluation of SARS-CoV-2 reinfection profiles
BACKGROUND: The emergence of SARS-CoV-2 variants has significantly increased the number of cases of COVID-19 among vaccinated individuals, raising concerns about the effectiveness of current vaccines. The aim of this study was to analyze the SARS-CoV-2 infection risks after primary vaccination with...
Autores principales: | Djorwé, Soulandi, Bousfiha, Amale, Nzoyikorera, Néhémie, Nyandwi, Joseph, Kawthar, Bellamine, Malki, Abderrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
China Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627210/ https://www.ncbi.nlm.nih.gov/pubmed/37937059 http://dx.doi.org/10.37796/2211-8039.1412 |
Ejemplares similares
-
Epidemiology, clinical characteristics and risk factors of coronavirus disease 2019 (COVID-19) in Casablanca
por: Djorwé, Soulandi, et al.
Publicado: (2023) -
BBIBP-CorV Vaccination against the SARS-CoV-2 Virus Affects the Gut Microbiome
por: Shen, Yang, et al.
Publicado: (2023) -
SARS-CoV-2-specific T Cell Immunity after Vaccination with Sputnik V and BBIBP-CorV
por: Babrukevich, Darya, et al.
Publicado: (2022) -
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
por: Wang, Hui, et al.
Publicado: (2020) -
Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination
por: Zhang, Yuwei, et al.
Publicado: (2023)